TBCC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.175700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.994200E-01
Normal-vs-Stage2
2.531800E-01
Normal-vs-Stage3
7.694300E-02
Normal-vs-Stage4
1.597800E-01
Stage1-vs-Stage2
2.109000E-01
Stage1-vs-Stage3
1.341020E-01
Stage1-vs-Stage4
3.553400E-01
Stage2-vs-Stage3
2.262400E-01
Stage2-vs-Stage4
7.798200E-01
Stage3-vs-Stage4
2.209000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.787600E-02
Normal-vs-AfricanAmerican
2.200800E-01
Normal-vs-Asian
1.073240E-01
Caucasian-vs-AfricanAmerican
3.768200E-01
Caucasian-vs-Asian
7.894400E-01
AfricanAmerican-vs-Asian
2.975800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.251800E-02
Normal-vs-Female
3.130100E-02
Male-vs-Female
4.931400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.425400E-01
Normal-vs-Age(41-60Yrs)
3.147400E-01
Normal-vs-Age(61-80Yrs)
3.593800E-02
Normal-vs-Age(81-100Yrs)
3.030800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.626400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.975200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.718200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.926000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.296600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.974400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.031810E-02
Normal-vs-Daily Drinker
9.740700E-03
Normal-vs-Weekly Drinker
3.322300E-02
Normal-vs-Occasional Drinker
3.176200E-01
Normal-vs-Social Drinker
4.219500E-02
Non Drinker-vs-Daily Drinker
7.805400E-01
Non Drinker-vs-Weekly Drinker
6.902000E-01
Non Drinker-vs-Occasional Drinker
8.829600E-02
Non Drinker-vs-Social Drinker
5.339600E-01
Daily Drinker-vs-Weekly Drinker
5.332600E-01
Daily Drinker-vs-Occasional Drinker
6.649800E-02
Daily Drinker-vs-Social Drinker
4.034000E-01
Weekly Drinker-vs-Occasional Drinker
2.108400E-01
Weekly Drinker-vs-Social Drinker
8.462800E-01
Occasional Drinker-vs-Social Drinker
2.583200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.404190E-01
Normal-vs-Grade 2
8.397400E-03
Normal-vs-Grade 3
3.605600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.280400E-01
Grade 1-vs-Grade 3
2.758200E-01
Grade 1-vs-Grade 4
1.404190E-01
Grade 2-vs-Grade 3
1.846200E-01
Grade 2-vs-Grade 4
8.397400E-03
Grade 3-vs-Grade 4
3.605600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.647620E-02
Normal-vs-NonDiabetic
2.911800E-02
Diabetic-vs-NonDiabetic
1.828230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.118000E-01
Normal-vs-NoPancreatitis
3.061600E-02
Pancreatitis-vs-NoPancreatitis
1.797510E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.770000E-01
Normal-vs-N1
2.517000E-01
N0-vs-N1
2.450200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.128200E-01
Normal-vs-TP53-NonMutant
2.725600E-01
TP53-Mutant-vs-TP53-NonMutant
1.816200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
